The plant disease diagnostics market size is expected to see strong growth in the next few years. It will grow to $1.11 billion by 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to increasing adoption of precision agriculture technologies, rising demand for sustainable crop protection solutions, growth in ai-enabled agricultural diagnostics, expansion of smart farming and iot-based monitoring systems, increasing investment in climate-resilient crop management solutions. Major trends in the forecast period include ai-based plant disease detection and predictive crop health analytics, iot-enabled smart farming sensors for real-time plant monitoring, drone-assisted field imaging for early disease identification, cloud-based agricultural diagnostic platforms for data-driven decision making, biotechnology-driven molecular pathogen identification and rapid field testing solutions.
The rising prevalence of crop diseases is expected to drive the growth of the plant disease diagnostics market going forward. Crop diseases refer to damaging conditions in plants caused by pathogens such as fungi, bacteria, viruses, or environmental factors that negatively affect crop health, development, and yield. The rising prevalence of crop diseases is attributed to changing climate conditions, which create warmer temperatures, shifting rainfall patterns, and increased humidity that support the spread and survival of plant pathogens. Plant disease diagnostics helps manage crop diseases by enabling early and precise identification of pathogens, allowing timely and targeted treatment that limits spread and reduces yield losses. For instance, in February 2025, according to the Crop Protection Network (CPN), a US-based university, in 2024, crop diseases affected corn yields by 6% in the United States and 3.7% in Ontario, leading to a total deficit of 963.4 million bushels. Therefore, the rising prevalence of crop diseases is driving the growth of the plant disease diagnostics market.
Leading companies operating in the plant disease diagnostics market are concentrating on developing innovative solutions, such as rapid molecular test kits, to support faster, accurate, and on-site detection of plant pathogens for timely disease management. Rapid molecular test kits are diagnostic tools that utilize molecular techniques such as DNA or RNA detection to rapidly identify specific pathogens in a sample, often providing results within minutes to hours. For instance, in February 2026, Agdia Inc. launched a rapid, field-deployable molecular test kit for the dual detection of Beet pseudoyellows virus (BPYV) and Strawberry pallidosis associated virus (SPaV) on its AmplifyRP XRT platform, along with a corresponding testing service option for growers. The kit supports rapid, on-site identification of both viruses using isothermal molecular technology, removing the need for complex laboratory equipment. It enables growers to detect infections early in strawberry and cucurbit crops, allowing quicker decision-making for disease management. The accompanying service also offers professional sample testing with rapid turnaround times to support large-scale monitoring and research initiatives.
In September 2024, Eurofins Agroscience Services acquired Verdelab Bioscience for an undisclosed amount. Through this acquisition, Eurofins Agroscience Services intends to expand its phytopathology testing services across Europe, strengthen its plant disease diagnostic capabilities for seeds and crops, and provide growers with rapid and accurate plant pathogen detection to support healthier crops and minimize economic losses caused by viral, bacterial, and fungal infections. Verdelab Bioscience S. r. l. is an Italy-based company that offers comprehensive plant disease diagnostics.
Major companies operating in the plant disease diagnostics market are Thermo Fisher Scientific Inc., Eurofins Scientific SE, Bio-Rad Laboratories Inc., QIAGEN N. V., Neogen Corporation, Promega Corporation, Creative Diagnostics, PanonIT LLC, Agdia Inc., Abingdon Health plc, Norgen Biotek Corp., Bioreba AG, Lifeasible Inc., Agritest S. r. l., ClearDetections B. V., LOEWE Biochemica GmbH, OptiGene Limited, Qualiplante SAS, AgroDiagnostica LLC, NIPPON GENE CO LTD.
North America was the largest region in the plant disease diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plant disease diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the plant disease diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The plant disease diagnostics market consists of revenues earned by entities by providing services such as pathogen identification services, seed health testing, water testing for pathogens, disease surveillance, and on-site diagnostics. The market value includes the value of related goods sold by the service provider or included within the service offering. The plant disease diagnostics market also includes sales of PCR-based detection kits, lateral flow test strips, DNA or RNA extraction kits, and next-generation sequencing library prep kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
Executive Summary
Plant Disease Diagnostics Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses plant disease diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for plant disease diagnostics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The plant disease diagnostics market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Kits And Reagents; Instruments; Software And Services2) By Technology: Molecular Diagnostics; Serological Methods; Immunodiagnostics; Other Technologies
3) By Sample Type: Leaves; Stems; Roots; Fruits; Seeds; Other Sample Types
4) By End-User: Agricultural Research Institutes; Diagnostic Laboratories; Farms; Greenhouses; Other End-Users
Subsegments:
1) By Kits And Reagents: Enzyme Linked Kits; Lateral Flow Kits; Nucleic Acid Extraction Kits; Polymerase Chain Reaction Reagents2) By Instruments: Real Time Polymerase Chain Reaction Machines; Next Generation Sequencers; Microarray Scanners; Biosensors
3) By Software And Services: Data Analysis Software; Cloud Based Diagnostic Platforms; Consulting Services; Laboratory Testing Services
Companies Mentioned: Thermo Fisher Scientific Inc.; Eurofins Scientific SE; Bio-Rad Laboratories Inc.; QIAGEN N.V.; Neogen Corporation; Promega Corporation; Creative Diagnostics; PanonIT LLC; Agdia Inc.; Abingdon Health plc; Norgen Biotek Corp.; Bioreba AG; Lifeasible Inc.; Agritest S.r.l.; ClearDetections B.V.; LOEWE Biochemica GmbH; OptiGene Limited; Qualiplante SAS; AgroDiagnostica LLC; NIPPON GENE CO LTD.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Plant Disease Diagnostics market report include:- Thermo Fisher Scientific Inc.
- Eurofins Scientific SE
- Bio-Rad Laboratories Inc.
- QIAGEN N.V.
- Neogen Corporation
- Promega Corporation
- Creative Diagnostics
- PanonIT LLC
- Agdia Inc.
- Abingdon Health plc
- Norgen Biotek Corp.
- Bioreba AG
- Lifeasible Inc.
- Agritest S.r.l.
- ClearDetections B.V.
- LOEWE Biochemica GmbH
- OptiGene Limited
- Qualiplante SAS
- AgroDiagnostica LLC
- NIPPON GENE CO LTD.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | July 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 0.82 Billion |
| Forecasted Market Value ( USD | $ 1.11 Billion |
| Compound Annual Growth Rate | 7.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |


